embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference
14 Dezember 2022 - 11:00PM
Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that
management will present at the J.P. Morgan Healthcare Conference in
San Francisco on Wednesday, January 11, 2023 at 9:45 a.m. PT /
12:45 p.m. ET.
Audio webcasts of the presentations will be accessible under the
“News & Events” section of the Company's investor relations
website at investors.embecta.com.
About embecta embecta, formerly part of BD
(Becton, Dickinson and Company), is one of the largest pure-play
diabetes care companies in the world, leveraging its nearly
100-year legacy in insulin delivery to empower people with diabetes
to live their best life through innovative solutions, partnerships
and the passion of more than 2,000 employees around the globe. For
more information, visit embecta.com.
CONTACTS Investors:Pravesh
Khandelwal VP, Head of Investor Relations 551-264-6547 Contact
IR
Media: Christian GlazarSr. Director, Corporate
Communications 908-821-6922 Contact Media
Relations
Embecta (NASDAQ:EMBCV)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Embecta (NASDAQ:EMBCV)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Embecta Corporation (NASDAQ): 0 Nachrichtenartikel
Weitere News-Artikel